For example, in Parkinson’s disease, variants have been described in an enhancer region of the synuclein alpha (SNCA) gene, a key gene in Parkinson’s disease pathogenesis, and shown to modulate gene expression, leading to an increased or decreased risk of developing Parkinson’s disease (7,8). Here, SNCA is linked to Parkinson disease.